| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Anguita-Sánchez, Manuel |
| dc.contributor.author | Soriano Colomé, Toni |
| dc.contributor.author | Nuñez Gil, Ivan Javier |
| dc.contributor.author | Gomez Doblas, Juan Jose |
| dc.contributor.author | Gonzalez-Juanatey, Carlos |
| dc.contributor.author | Barrios, Vivencio |
| dc.contributor.author | Garcia-Moll, Xavier |
| dc.date.accessioned | 2022-11-23T13:17:40Z |
| dc.date.available | 2022-11-23T13:17:40Z |
| dc.date.issued | 2022-10-11 |
| dc.identifier.citation | González-Juanatey C, Anguita-Sánchez M, Barrios V, Núñez-Gil I, Gómez-Doblas JJ, García-Moll X, et al. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing. J Clin Med. 2022 Oct 12;11(20):6004. |
| dc.identifier.issn | 2077-0383 |
| dc.identifier.uri | https://hdl.handle.net/11351/8527 |
| dc.description | Diabetes mellitus; Natural language processing; Risk factors |
| dc.description.abstract | Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at high risk of developing major adverse cardiovascular events (MACE). This is a multicenter, retrospective, and observational study performed in Spain aimed to characterize these patients in a real-world setting. Unstructured data from the Electronic Health Records were extracted by EHRead®, a technology based on Natural Language Processing and machine learning. The association between new MACE and the variables of interest were investigated by univariable and multivariable analyses. From a source population of 2,184,662 patients, we identified 4072 adults diagnosed with T2DM and CAD (62.2% male, mean age 70 ± 11). The main comorbidities observed included arterial hypertension, hyperlipidemia, and obesity, with metformin and statins being the treatments most frequently prescribed. MACE development was associated with multivessel (Hazard Ratio (HR) = 2.49) and single coronary vessel disease (HR = 1.71), transient ischemic attack (HR = 2.01), heart failure (HR = 1.32), insulin treatment (HR = 1.40), and percutaneous coronary intervention (PCI) (HR = 2.27), whilst statins (HR = 0.73) were associated with a lower risk of MACE occurrence. In conclusion, we found six risk factors associated with the development of MACE which were related with cardiovascular diseases and T2DM severity, and treatment with statins was identified as a protective factor for new MACE in this study. |
| dc.language.iso | eng |
| dc.publisher | MDPI |
| dc.relation.ispartofseries | Journal of Clinical Medicine;11(20) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Malalties coronàries - Factors de risc |
| dc.subject | Diabetis - Factors de risc |
| dc.subject | Històries clíniques - Informàtica |
| dc.subject.mesh | Electronic Health Records |
| dc.subject.mesh | Coronary Artery Disease |
| dc.subject.mesh | Diabetes Mellitus |
| dc.title | Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3390/jcm11206004 |
| dc.subject.decs | historias clínicas electrónicas |
| dc.subject.decs | enfermedad arterial coronaria |
| dc.subject.decs | diabetes mellitus |
| dc.relation.publishversion | https://doi.org/10.3390/jcm11206004 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [González-Juanatey C] Hospital Universitario Lucus Augusti, Lugo, Spain. [Anguita-Sánchez M] Hospital Universitario Reina Sofía, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain. [Barrios V] Hospital Universitario Ramón y Cajal, Madrid, Spain. [Núñez-Gil I] Hospital Clínico Universitario San Carlos, Madrid, Spain. [Gómez-Doblas JJ] Hospital Universitario Virgen de la Victoria CIBERCV (Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares) and IBIMA (Instituto de Investigación Biomédica de Málaga), Málaga, Spain. [García-Moll X] Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain. [Soriano-Colomé T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBERCV, Barcelona, Spain |
| dc.identifier.pmid | 36294325 |
| dc.identifier.wos | 000872820300001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |